what does 2022 hold for pharma companies? | a vaidheesh & nithya balasubramanian
Published 2 years ago • 923 plays • Length 11:32Download video MP4
Download video MP3
Similar videos
-
13:34
pain in pharma pack? | nithya balasubramanian, sanford bernstein & a vaidheesh, former md,gsk pharma
-
9:35
where is value in pharma pack? | nithya balasubramanian, sanford bernstein
-
6:59
cipla vs sun pharma - is pharma ready for a turnaround? | nithya balasubramanian, sanford bernstein
-
6:49
what is in the covid portfolio of top pharma companies? | nithya balasubramanian to et now
-
13:00
why the buzz in pharma stocks | nithya balasubramanian & kewal handa discuss
-
26:27
data update 3 for 2022: the inflation effect on investing
-
3:27
these 10 pharma & healthcare stocks are among the latest favourites of mutual fund managers
-
46:26
ft pharma 2021 - pricing and market access trends session
-
11:44
next pharma stuff - speaking with vanitha venkatasubramaniam
-
12:30
is pharma ripe for re-rating? | nithya balasubramanian of sanford bernstein to et now
-
10:00
how's the generics market shaping up in pharma sector? | nithya balasubramanian | et now
-
8:49
robust q2 for indian pharma | nithya balasubramanian of sanford bernstein to et now
-
14:26
nithya balasubramanian explains why pharma stocks are buzzing
-
8:55
pecking order for indian pharma cos | moving past u.s. pricing pressure? | nithya balasubramanian
-
15:32
investors concerned about us generic pricing pressure | nithya balasubramanian, sanford bernstein
-
12:02
will pharma stocks rally continue? nithya balasubramanian of bernstein | business news
-
3:44
8 reasons to invest in pharma & healthcare
-
10:11
sanford bernstein's nithya balasubramanian's take on pharma stocks amid covid-19 concerns
-
1:29
tnpl - why do we need the new legislation
-
7:57
sanford bernstein's nithya balasubramanian on q4 results of pharma cos & china opportunity
-
5:50
covid-19 concerns re-surface: what can this translate into for pharma? : vishal manchanda exclusive